Literature DB >> 10576669

Reproducibility of microvessel counts in breast cancer specimens.

L P Marson1, K M Kurian, W R Miller, J M Dixon.   

Abstract

Assessment of tumour vascularity in core biopsy specimens may be a useful predictor of response to primary therapy. This study addresses practical methodological issues regarding accuracy of tumour vascularity assessments in different breast cancer specimens. Issues addressed in the study are variation caused by (i) inherent observer variation in the method, (ii) tumour heterogeneity and (iii) previous surgical manipulation of tumours. Microvessel counts were performed by two observers on separate occasions and by two different observers. Counts were performed on core biopsies and tumour sections taken simultaneously (n = 16) and with an intervening time interval (n = 21). In addition core biopsies were obtained from the same tumour on two separate occasions (n = 10). A highly significant correlation was found in counts performed by the same observers at different times and between two different observers. No significant correlation was found in counts of core biopsies and tumour sections taken either simultaneously or subsequently. No correlation was found between counts of sequential core biopsies. Study findings suggest that, although microvessel counts may be assessed reproducibly by the same and different observers, counts performed in core biopsies do not accurately reflect those of overall tumour, limiting their potential as predictive or prognostic markers.

Entities:  

Mesh:

Year:  1999        PMID: 10576669      PMCID: PMC2362946          DOI: 10.1038/sj.bjc.6690811

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.

Authors:  D V Parums; J L Cordell; K Micklem; A R Heryet; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

2.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

4.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

5.  Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density.

Authors:  S Hansen; D A Grabau; C Rose; M Bak; F B Sørensen
Journal:  Lab Invest       Date:  1998-12       Impact factor: 5.662

6.  Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer.

Authors:  M E Van Hoef; W F Knox; S S Dhesi; A Howell; A M Schor
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

7.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Authors:  N Weidner; J Folkman; F Pozza; P Bevilacqua; E N Allred; D H Moore; S Meli; G Gasparini
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

8.  Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies.

Authors:  M G Daidone; S Orefice; M Mastore; G Santoro; B Salvadori; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

9.  TRU-CUT needle biopsy of the breast. An analysis of its specificity and sensitivity.

Authors:  S Minkowitz; R Moskowitz; R A Khafif; M N Alderete
Journal:  Cancer       Date:  1986-01-15       Impact factor: 6.860

10.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

View more
  1 in total

1.  Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women.

Authors:  B B da Silva; A R dos Santos; C G Pires; P V Lopes-Costa
Journal:  Cell Prolif       Date:  2009-05-29       Impact factor: 6.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.